Valuation: Boule Diagnostics AB

Market Cap 136M 13.95M 12.27M 11.4M 10.48M 19.66M 1.35B 20.01M 53.17M 659M 52.37M 51.24M 2.29B P/E 2026 *
-13.9x
P/E 2027 * 15.9x
Enterprise Value 333M 34.07M 29.96M 27.83M 25.6M 48.01M 3.3B 48.87M 130M 1.61B 128M 125M 5.58B EV / Sales 2026 *
0.73x
EV / Sales 2027 * 0.66x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day+4.15%
1 week-6.40%
Current month-5.39%
1 month+1.45%
3 months-10.00%
6 months-29.80%
Current year-28.51%
1 week 3.24
Extreme 3.24
3.76
1 month 2.75
Extreme 2.75
3.99
Current year 2.75
Extreme 2.75
5.68
1 year 2.75
Extreme 2.75
6.7
3 years 2.75
Extreme 2.75
12.62
5 years 2.75
Extreme 2.75
61.2
10 years 2.75
Extreme 2.75
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap.
2/27/23 A Buy

Chief Financial Officer

8,000 0.0206%
2/6/23 A Buy

Director

7,083 0.0182%
2/17/22 A Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+4.15%-6.40%-46.82%-69.21% 13.95M
+8.71%+5.36%+22.63%+1.80% 213B
+7.46%-6.10%-2.72%-24.77% 135B
-2.54%-17.48%-33.85%-1.38% 117B
+1.42%-2.33%-59.56%-18.02% 64.78B
-0.65%-4.58%+8.98%-9.45% 48.26B
-1.56%-3.21%-26.85%-33.72% 43.08B
+4.71%+2.67%+16.97%+9.50% 39.47B
+3.13%+1.12%+29.35%+32.45% 37.55B
+3.14%+3.47%+88.18%+3.34% 29.78B
Average +2.70%-3.67%-0.37%-10.95% 72.82B
Weighted average by Cap. +3.92%-4.90%+0.40%-6.20%

Financials

2026 *2027 *
Net sales 453M 46.38M 40.79M 37.89M 34.85M 65.36M 4.49B 66.53M 177M 2.19B 174M 170M 7.6B 483M 49.47M 43.51M 40.42M 37.17M 69.71M 4.79B 70.96M 189M 2.34B 186M 182M 8.11B
Net income -9.77M -1M -880K -817K -752K -1.41M -96.87M -1.43M -3.81M -47.25M -3.76M -3.67M -164M 8.6M 880K 774K 719K 661K 1.24M 85.21M 1.26M 3.35M 41.56M 3.3M 3.23M 144M
Net Debt 197M 20.12M 17.69M 16.44M 15.12M 28.35M 1.95B 28.86M 76.66M 950M 75.52M 73.89M 3.3B 185M 18.89M 16.61M 15.43M 14.19M 26.61M 1.83B 27.09M 71.97M 892M 70.9M 69.37M 3.09B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
23/07/26 SEK 3.510 +4.15% 6,644
22/07/26 SEK 3.370 +0.30% 13,719
21/07/26 SEK 3.360 -6.67% 13,421
20/07/26 SEK 3.600 +4.35% 5,866
17/07/26 SEK 3.450 -8.00% 254,379
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.510SEK
Average target price
3.800SEK
Spread / Average Target
+8.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock